| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $42.1M | +15.2% |
| R&D Expense | $143.9M | +24.9% |
| SG&A Expense | $43.7M | +23.2% |
| Operating Income | -$145.6M | -27.5% |
| Pre-tax Income | -$130.1M | -28.0% |
| Income Tax | $208K | +55.2% |
| Net Income | -$130.3M | -28.1% |
| EPS (Basic) | -$1.19 | -10.2% |
| EPS (Diluted) | -$1.19 |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $69.5M | +4.7% |
| Short-term Investments | $188.4M | -30.4% |
| Current Assets | $266.3M | -23.1% |
| Total Assets | $316.5M | -21.4% |
| Current Liabilities | $38.2M | -16.9% |
| Total Liabilities | $117.0M | -21.7% |
| Stockholders' Equity | $199.5M | -21.2% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$131.5M | -11.5% |
| Capital Expenditures | $754K | -50.6% |
| Investing Cash Flow | $86.1M | +107.9% |
| Financing Cash Flow | $47.7M | -42.2% |
| Free Cash Flow | -$132.3M | -10.7% |
| -10.2% |